Bora Pharmaceuticals is led by Bobby Sheng, who serves as the Chief Executive Officer and driving force behind the company's international expansion as a premier contract development and manufacturing organization. Under his executive leadership, the enterprise has grown its global operational footprint through strategic acquisitions of manufacturing facilities across North America and Asia, enabling the company to provide comprehensive oral solid, liquid, and sterile injectable development services to major global pharmaceutical clients.